| Literature DB >> 25480685 |
Jeremy R Dettman1, Nicolas Rodrigue2, Rees Kassen3.
Abstract
The bacterium Pseudomonas aeruginosa is a significant cause of acute nosocomial infections as well as chronic respiratory infections in patients with cystic fibrosis (CF). Recent reports of the intercontinental spread of a CF-specific epidemic strain, combined with high intrinsic levels of antibiotic resistance, have made this opportunistic pathogen an important public health concern. Strain-specific differences correlate with variation in clinical outcomes of infected CF patients, increasing the urgency to understand the evolutionary origin of genetic factors conferring important phenotypes that enable infection, virulence, or resistance. Here, we describe the genome-wide patterns of homologous and nonhomologous recombination in P. aeruginosa, and the extent to which the genomes are affected by these diversity-generating processes. Based on whole-genome sequence data from 32 clinical isolates of P. aeruginosa, we examined the rate and distribution of recombination along the genome, and its effect on the reconstruction of phylogenetic relationships. Multiple lines of evidence suggested that recombination was common and usually involves short stretches of DNA (200-300 bp). Although mutation was the main source of nucleotide diversity, the import of polymorphisms by homologous recombination contributed nearly as much. We also identified the genomic regions with frequent recombination, and the specific sequences of recombinant origin within epidemic strains. The functional characteristics of the genes contained therein were examined for potential associations with a pathogenic lifestyle or adaptation to the CF lung environment. A common link between many of the high-recombination genes was their functional affiliation with the cell wall, suggesting that the products of recombination may be maintained by selection for variation in cell-surface molecules that allows for evasion of the host immune system.Entities:
Keywords: adaptation; comparative genomics; epidemic; homologous recombination; horizontal transfer; population genomics
Mesh:
Year: 2014 PMID: 25480685 PMCID: PMC4316616 DOI: 10.1093/gbe/evu260
Source DB: PubMed Journal: Genome Biol Evol ISSN: 1759-6653 Impact factor: 3.416
Information on the 32 Pseudomonas aeruginosa Genomes
| Isolate | City of Isolation | Source | Epidemic | GenBank Accesion | Genome State | Assembly Length (bp) |
|---|---|---|---|---|---|---|
| JD303 | Toronto, Canada | CF patient | No | AWYU00000000 | Draft | 6,353,798 |
| JD304 | Ottawa, Canada | CF patient | LESA | AWYT00000000 | Draft | 6,439,488 |
| JD306 | Toronto, Canada | CF patient | No | AWYS00000000 | Draft | 6,647,721 |
| JD310 | Ottawa, Canada | CF patient | LESA | AWYR00000000 | Draft | 6,424,472 |
| JD312 | Kitchener, Canada | CF patient | No | AWYQ00000000 | Draft | 6,299,443 |
| JD313 | Hamilton, Canada | CF patient | ESB | AWYP00000000 | Draft | 6,348,777 |
| JD314 | Kitchener, Canada | CF patient | No | AWYO00000000 | Draft | 6,233,472 |
| JD315 | Hamilton, Canada | CF patient | LESA | AWYN00000000 | Draft | 6,406,347 |
| JD316 | Sudbury, Canada | CF patient | ESB | AWYM00000000 | Draft | 6,215,338 |
| JD317 | Toronto, Canada | CF patient | No | AWYL00000000 | Draft | 6,511,721 |
| JD318 | Hamilton, Canada | CF patient | No | AWYK00000000 | Draft | 6,230,857 |
| JD320 | Toronto, Canada | CF patient | No | AWYJ00000000 | Draft | 6,435,861 |
| JD322 | Toronto, Canada | CF patient | LESA | AWYV00000000 | Draft | 6,478,170 |
| JD323 | Hamilton, Canada | CF patient | No | AWYW00000000 | Draft | 5,996,350 |
| JD324 | Toronto, Canada | CF patient | LESA | AWYX00000000 | Draft | 6,432,592 |
| JD325 | Hamilton, Canada | CF patient | No | AWYY00000000 | Draft | 6,294,013 |
| JD326 | Hamilton, Canada | CF patient | LESA | AWYZ00000000 | Draft | 6,470,946 |
| JD328 | London, Canada | CF patient | ESB | AWZA00000000 | Draft | 6,346,874 |
| JD329 | London, Canada | CF patient | LESA | AWZB00000000 | Draft | 6,430,078 |
| JD331 | London, Canada | CF patient | ESB | AWZC00000000 | Draft | 6,345,919 |
| JD332 | Ottawa, Canada | CF patient | No | AWZD00000000 | Draft | 6,183,240 |
| JD333 | Toronto, Canada | CF patient | ESB | AWZE00000000 | Draft | 6,350,229 |
| JD334 | Sudbury, Canada | CF patient | No | AWZF00000000 | Draft | 6,730,042 |
| JD335 | Toronto, Canada | CF patient | LESA | AWZG00000000 | Draft | 6,401,946 |
| PA14 | Burn patient | No | NC_008463 | Finished | 6,537,648 | |
| LESB58 | Liverpool, England | CF patient | LESA | NC_011770 | Finished | 6,601,757 |
| PAO1 | Melbourne, Australia | Wound | No | NC_002516 | Finished | 6,264,404 |
| PACS2 | CF patient, paediatric | No | NZ_AAQW00000000 | Draft | 6,492,423 | |
| PA2192 | Boston, USA | CF patient | No | NZ_AAKW00000000 | Draft | 6,826,253 |
| PA39016 | Keratitis | No | NZ_AEEX00000000 | Draft | 6,667,333 | |
| C3719 | Manchester, England | CF patient | putative epidemic strain | NZ_AAKV00000000 | Draft | 6,146,998 |
| PAb1 | Frostbite patient | No | NZ_ABKZ00000000 | Draft | 6,078,600 |
Results Summary of ClonalFrame Runs Applied to Full Core Genome Alignment
| Run | υ (95% CI) | ρ (95% CI) | δ (95% CI) | ρ/θ (95% CI) | |
|---|---|---|---|---|---|
| 1 | 0.019 (0.015, 0.024) | 5735.0 (4577.7, 7215.8) | 271.3 (204.9, 353.8) | 0.168 (0.134, 0.211) | 0.801 (0.630, 0.988) |
| 2 | 0.020 (0.015, 0.026) | 5887.8 (4530.5, 7362.6) | 254.1 (183.9, 346.8) | 0.172 (0.132, 0.215) | 0.806 (0.617, 0.994) |
| 3 | 0.020 (0.015, 0.026) | 6073.2 (4655.1, 8387.5) | 257.7 (188.1, 341.2) | 0.178 (0.136, 0.245) | 0.840 (0.647, 1.101) |
| 4 | 0.016 (0.013, 0.018) | 6555.2 (5265.7, 7766.2) | 322.0 (262.9, 414.6) | 0.192 (0.154, 0.227) | 0.917 (0.738, 1.092) |
| 5 | 0.018 (0.013, 0.022) | 5969.9 (4756.3, 7328.0) | 301.7 (218.6, 408.6) | 0.175 (0.139, 0.214) | 0.850 (0.670, 1.047) |
| 6 | 0.020 (0.016, 0.023) | 6342.8 (5117.9, 7497.1) | 252.8 (200.5, 310.8) | 0.186 (0.149, 0.219) | 0.859 (0.693, 1.008) |
| 7 | 0.020 (0.017, 0.022) | 6771.9 (5480.5, 8108.2) | 249.3 (209.5, 292.0) | 0.198 (0.160, 0.237) | 0.899 (0.734, 1.059) |
Note.—υ, rate of new polymorphism introduced by recombination; ρ, recombination rate; δ, recombination tract length; ρ/θ, ratio of rates at which recombination and mutation occur; r/m, ratio of probabilities that a given site is altered through recombination and mutation; CI, credible interval.
FDistance-dependent decay of LD. The main graph shows a high-resolution view of the distance range that is shaded in the inset graph.
FComparison of phylogenetic trees constructed from different core genome data sets. (A) ML phylogeny of full core genome which contained 137,941 SNPs. Black branches had greater than 70% bootstrap support whereas gray branches had less than 70% bootstrap support. (B) ML phylogeny of nonrecombinant regions of core genome, which contained 124,926 SNPs. Branch shading indicates branch support as in A. (C) Majority-rule consensus tree from the ClonalFrame run with the highest mean likelihood. Black branches were present in the majority-rule consensus tree of all seven independent ClonalFrame runs combined, whereas gray branches were not.
FComparison of topologies of trees constructed from 0.2 Mb subsets of the core genome. Trees are placed directly above the alignment segment from which they were constructed. For the sake of comparison, all topologies are displayed with JD317 at the top. The average normalized Robinson–Foulds distance between all possible pairs of trees was 0.94.
FRarefaction curves for the size of the core genome and pan-genome. Means are plotted with 25 and 75 percentiles.
FPlot of the number of recombination events along the core genome alignment. Values are means calculated from a sliding window of 500 sites (thick red line) or 20 sites (thin blue line). Crosses along the top indicate regions with high frequency of recombination. Circles along the top indicate regions with high nucleotide diversity (from Dettman et al. 2013).
List of Genes within Core Genome Regions of High Recombination
| Functional Class | Gene ID in PAO1 | Functional Information from |
|---|---|---|
| Secretion and transport | PA0082 | |
| PA0470 | ||
| PA4235 | ||
| PA3670 | Auxiliary component of ABC transporter, gliding motility | |
| PA3597 | Amino acid permease, ABC transporter | |
| PA3520 | Putative heavy metal binding protein, transport/detoxification, copper binding | |
| PA4541 | ||
| PA4770 | ||
| PA4898 | ||
| PA5090 | Type-VI secretion protein, Rhs element, Vgr-family protein | |
| PA5248 | Cytochrome c/iron permease family protein | |
| PA5249 | Amino acid/homoserine lactone transporter, quorum sensing and biofilm formation | |
| Cell wall metabolism | PA3734 | Putative lipase |
| PA3239 | Putative vacJ-family surface lipoprotein | |
| PA3141 | ||
| PA3127 | Putative bleomycin resistance protein, glyoxalase/dioxygenase | |
| PA2977 | ||
| PA2403 | Peptidase, iron-regulated membrane protein | |
| PA4528 | ||
| PA4999 | ||
| PA5000 | ||
| PA5089 | Putative phospholipase | |
| Resistance | PA0595 | |
| PA3521 | ||
| PA2850 | ||
| PA2849 | ||
| PA4521 | ||
| Miscellaneous | PA0495 | Putative hydrolase, urea metabolism |
| PA4234 | ||
| PA3735 | ||
| PA3669 | Hypothetical protein | |
| PA3596 | Probable methylated-DNA-protein-cysteine methyltransferase | |
| PA3589 | Acetyl-CoA acetyltransferase, acyl-CoA thiolase | |
| PA3240 | Conserved hypothetical protein, pirin-related protein | |
| PA3163 | ||
| PA2978 | ||
| PA2976 | ||
| PA2852 | Hypothetical protein | |
| PA2839 | ||
| Not called | Hypothetical protein (pseudogene) | |
| PA2573 | Chemotaxis transducer, methyl-accepting chemotaxis protein | |
| Not called | Hypothetical protein | |
| PA1930 | Chemotaxis transducer, methyl-accepting chemotaxis protein | |
| Not called | Putative GntR-family transcriptional regulator | |
| PA1510 | Hypothetical membrane protein | |
| PA1509 | Hypothetical protein | |
| PA1377 | ||
| PA1394 | Hypothetical protein | |
| PA1267 | Putative D-amino acid oxidase, FAD-dependent oxidoreductase | |
| PA0711 | Probable acetyltransferase | |
| PA0710 | ||
| PA4523 | Probable thymidine phosphorylase | |
| PA4524 | ||
| PA4949 |
List of Genes within Regions of Recombinant Origin Shared between Two Epidemic Strains (LESA and ESB)
| Gene ID in PAO1 | Gene ID in LESB58 | Functional Information from |
|---|---|---|
| PA0077 | PALES_00781 | |
| PA0133 | PALES_01341 | |
| PA0349 | PALES_03461 | Hypothetical protein |
| PA0480 | PALES_04761 | Hydrolase, 3-oxoadipate enol-lactonase |
| PA0556 | PALES_05541 | Hypothetical protein |
| PA0588 | PALES_05851 | PrkA-family serine protein kinase ( |
| PA4136 | PALES_08351 | Major facilitator superfamily (MFS) transporter, multidrug efflux |
| PA4082 | PALES_08941 | |
| PA3895 | PALES_10821 | LysR-family transcriptional regulator |
| PA3778 | PALES_11961 | LysR family transcriptional regulator |
| PA3589 | PALES_14451 | Acetyl-CoA acetyltransferase, acyl-CoA thiolase |
| PA3324 | PALES_17401 | Short chain dehydrogenase |
| PA3272 | PALES_17951 | ATP-dependent DNA helicase |
| PA2873 | PALES_21911 | |
| PA1375 | PALES_38101 | |
| PA1476 | PALES_39371 | |
| PA1475 | PALES_39381 | |
| PA0671 | PALES_46581 | Hypothetical protein |
| PA4444 | PALES_48231 | |
| PA4523 | PALES_49041 | Thymidine phosphorylase |
| PA4543 | PALES_49261 | Multicopper polyphenol oxidoreductase |
| PA4571 | PALES_49541 | Cytochrome c |
| PA4700 | PALES_50851 | |
| PA4701 | PALES_50861 | Conserved hypothetical protein |
| PA4733 | PALES_51181 | |
| PA4779 | PALES_51641 | ABC transporter permease |
| PA5090 | PALES_54801 | Type-VI secretion protein, Rhs element, Vgr-family protein |
| PA5323 | PALES_57181 | |
| PA5324 | PALES_57191 | Transcriptional regulator, AraC family |
| PA5349 | PALES_57441 | Rubredoxin-NAD(+) reductase |